Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
21,198,794
-
Share change
-
+21,018,388
-
Total reported value
-
$97,089,813
-
Price per share
-
$4.58
-
Number of holders
-
28
-
Value change
-
+$96,755,407
-
Number of buys
-
25
-
Number of sells
-
5
Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2025
As of 30 Sep 2025,
Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,198,794 shares.
The largest 10 holders included
Pantera Capital Partners LP, Ikarian Capital, LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, BIT Capital GmbH, CITADEL ADVISORS LLC, and Virtu Financial LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.